| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |